Kursinformationen (Nasdaq)
- Tagestief / Hoch-
- 52W-Tief / Hoch53,710-77,700
- Jahrestief / Hoch20,630-82,000
- Volumen Intraday
Wichtigste Eigenschaften
Werbung
Schnellsuche von
Termine von Axsome Therapeutics Inc.
- Mai9Axsome Therapeutics Inc.Q1 2023 Earnings Release
- Aug9Axsome Therapeutics Inc.Q2 2023 Earnings Release
Beschreibung
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.
Pivot-Points (Nasdaq)
NameWert
- Pivot-HBOP - R365,103 $
- Pivot-Resist - R263,999 $
- Pivot-High - R163,219 $
- Pivotpunkt62,115 $
- Pivot-Low - S161,335 $
- Pivot-Support - S260,231 $
- Pivot-LBOP - S359,451 $
Passender Service zu Axsome Therapeutics Inc.
Webinar zu Axsome Therapeutics Inc.
Axsome Therapeutics Inc. Kurse
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit |
|---|---|---|---|---|---|
Wichtige Bewertungskennzahlen
Keine Kennzahlen vorhanden
Passende Produkte
Wertentwicklung (Nasdaq)
-3,41 %
Intraday
-2,74 %
1 Woche
-7,67 %
1 Monat
-21,81 %
Seit Jahresbeginn
50,70 %
1 Jahr
4,74 %
3 Jahre
2.361,63 %
5 Jahre
Peer Group
Novo-Nordisk AS 321,37 Mrd. €
Regeneron Pharmaceuticals Inc. 90,41 Mrd. $
Vertex Pharmaceuticals Inc. 80,53 Mrd. $
Moderna Inc. 56,66 Mrd. $
Seagen Inc. 37,99 Mrd. $
Alnylam Pharmaceuticals Inc 23,40 Mrd. $
argenx SE 18,76 Mrd. €
Biomarin Pharmaceutical Inc. 17,06 Mrd. $
UCB S.A. 15,24 Mrd. €
ROYALTY PHARMA PLC Reg.Ord.Cl.A Shares DL-,0001 16,43 Mrd. $
